Table 2.
Average relapse rate during follow-up period
| Period from index date to the end of F/U, among patients who initiated LAI after index date (N = 2222) | |||
|---|---|---|---|
| From index date to LAI initiation | From LAI initiation to end of F/U | P value | |
| Relapse rate (PPPM)a,b | 0.109 | 0.073 | < 0.0001 |
| Hospitalization rate (PPPM) | 0.091 | 0.058 | < 0.0001 |
| ER rate (PPPM) | 0.017 | 0.015 | 0.2552 |
ER emergency room, F/U follow-up, LAI long-acting injectable, PPPM per patient per month
aRelapse is defined as hospitalization or ER visits with a diagnosis of schizophrenia as primary or secondary diagnosis, assessed from index date to the end of follow-up (F/U) period
bRate in PPPM is calculated as “number of events within the specific period” divided by “duration of the specific period in months” for a given patient